Ethical and regulatory considerations for safeguarding participants in bispecific antibody clinical trials, and best practices designed to optimize their success.
Sharad Adekar, MD, PhD, CIP
Advertisement
Senior Medical Chair at WCG’s IRB in Puyallup, Washington
Articles by Sharad Adekar, MD, PhD, CIP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Releases Transparency Roadmap Outlining Disclosure Priorities Across Drug Development and Regulatory Review
2
FDA Seeks Public Input on Early-Phase Clinical Trial Design for Ibogaine
3
ACT Brief: FDA Transparency Roadmap, Radiopharmaceutical Trial Operations, and AI-Powered Enrollment Prediction
4
Using AI to Design Better Trials Before the First Patient Enrolls: Q&A with Claire Riches, Citeline
5